Literature DB >> 25592380

MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.

Xiaolin Liu1, Ruifen Dong, Zhijun Jiang, Yuyan Wei, Yingwei Li, Linxuan Wei, Hengzi Sun, Yinuo Li, Ning Yang, Qifeng Yang, Zhaojian Liu, Beihua Kong.   

Abstract

Ovarian cancer is a highly invasive cancer with poor prognosis. Previous studies have revealed lots of connections between the invasiveness and epithelial-mesenchymal transition (EMT), which is common during the progression of ovarian cancer. MDC1, a mediator of DNA damage checkpoint, has recently been implicated as a potential oncogene. Here, in this article, we studied the role of MDC1 in ovarian cancer metastasis. First, in tissue samples, we found that high expression level of MDC1 was correlated with poor prognosis. Furthermore, MDC1 overexpression in ovarian cancer cells significantly increased migration and invasion. In contrast, silencing MDC1 reversed these processes. Consistently, nude mice xenograft confirmed that silencing MDC1 suppressed tumor metastasis in vivo. We further demonstrated that MDC1 induced EMT through modulation EMT markers such as E-cadherin, N-cadherin, and vimentin. Taken together, our findings suggest that MDC1 promotes ovarian cancer metastasis through the induction of EMT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592380     DOI: 10.1007/s13277-015-3063-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Sonia Franco; Monica Gostissa; Melissa A Rivera; Arkady Celeste; John P Manis; Jan van Deursen; André Nussenzweig; Tanya T Paull; Frederick W Alt; Junjie Chen
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

2.  MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.

Authors:  Manuel Stucki; Julie A Clapperton; Duaa Mohammad; Michael B Yaffe; Stephen J Smerdon; Stephen P Jackson
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

3.  JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks.

Authors:  Sugiko Watanabe; Kenji Watanabe; Vyacheslav Akimov; Jirina Bartkova; Blagoy Blagoev; Jiri Lukas; Jiri Bartek
Journal:  Nat Struct Mol Biol       Date:  2013-11-17       Impact factor: 15.369

Review 4.  MDC1: The art of keeping things in focus.

Authors:  Stephanie Jungmichel; Manuel Stucki
Journal:  Chromosoma       Date:  2010-03-12       Impact factor: 4.316

Review 5.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 6.  In brief: BRCA1 and BRCA2.

Authors:  William D Foulkes; Andrew Y Shuen
Journal:  J Pathol       Date:  2013-08       Impact factor: 7.996

Review 7.  MDC1/NFBD1: a key regulator of the DNA damage response in higher eukaryotes.

Authors:  Manuel Stucki; Stephen P Jackson
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

Review 8.  Beyond DNA repair: DNA-PK function in cancer.

Authors:  Jonathan F Goodwin; Karen E Knudsen
Journal:  Cancer Discov       Date:  2014-08-28       Impact factor: 39.397

9.  Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.

Authors:  X Wei Meng; Brian D Koh; Jin-San Zhang; Karen S Flatten; Paula A Schneider; Daniel D Billadeau; Allan D Hess; B Douglas Smith; Judith E Karp; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

10.  Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma.

Authors:  Mi-Kyung Kim; Min A Kim; Haeryoung Kim; Yong-Beom Kim; Yong-Sang Song
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

View more
  8 in total

1.  DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.

Authors:  Giuliana De Gregoriis; Juliene Antonio Ramos; Priscila Valverde Fernandes; Giselle Maria Vignal; Rafael Canfield Brianese; Dirce Maria Carraro; Alvaro N Monteiro; Claudio José Struchiner; Guilherme Suarez-Kurtz; Rosane Vianna-Jorge; Marcelo Alex de Carvalho
Journal:  Cancer Biol Ther       Date:  2017-05-05       Impact factor: 4.742

2.  MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells.

Authors:  Lin Lin; Zhiwen Wang; Haihong Jin; Hongzhen Shi; Zhihong Lu; Zhenqin Qi
Journal:  Tumour Biol       Date:  2016-11-03

3.  LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.

Authors:  S Wang; Z Zou; X Luo; Y Mi; H Chang; D Xing
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

Review 4.  Roles for MDC1 in cancer development and treatment.

Authors:  Sophie E Ruff; Susan K Logan; Michael J Garabedian; Tony T Huang
Journal:  DNA Repair (Amst)       Date:  2020-08-11

Review 5.  Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Authors:  Larion Santiago; Garrett Daniels; Dongwen Wang; Fang-Ming Deng; Peng Lee
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

6.  ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kwong-Kwok Wong; Arthur Gutierrez-Hartmann; Joseph Kwong; David M Gershenson; Samuel C Mok
Journal:  Oncotarget       Date:  2017-03-07

7.  Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites.

Authors:  Jihane Basbous; Antoine Aze; Laurent Chaloin; Rana Lebdy; Dana Hodroj; Cyril Ribeyre; Marion Larroque; Caitlin Shepard; Baek Kim; Alain Pruvost; Jérôme Moreaux; Domenico Maiorano; Marcel Mechali; Angelos Constantinou
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

Review 8.  Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells.

Authors:  Jingnan Xu; Zhuo Song; Qiujun Guo; Jie Li
Journal:  Biomed Res Int       Date:  2016-03-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.